Multiple large-surface photodynamic therapy sessions with topical or systemic aminolevulinic acid and blue light in UV-exposed hairless mice

Journal of Cutaneous Medicine and Surgery

Volumn 8, Issue 2, 2004, Pages 131-139

  Liu, Younan ^a   Viau, Gilles ^a   Bissonnette, Robert ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLUE LIGHT; CANCER PREVENTION; CONTROLLED STUDY; FEMALE; MOUSE; NONHUMAN; NUDE MOUSE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PUVA; RADIATION CARCINOGENESIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET IRRADIATION;

EID: 2942674408     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1177/120347540400800210     Document Type: Article

References (15)

1. Wang I, Bendsoe N, Klinteberg CA, et al. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial Br J Dermatol 2001; 1444:832-840.
2. Morton CA, Whitehurst C, McColl JH, et al. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma Arch Dermatol 2001; 1373:319-324.
3. Hongcharu W, Taylor CR, Chang Y, et al. Topical ALA-photodynamic therapy for the treatment of acne vulgaris J Invest Dermatol 2000; 1152:183-192.
4. Stender IM, Na R, Fogh H, et al. Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial Lancet 2000; 3559208:963-966.
5. Shieh S, Dee AS, Cheney RT, et al. Photodynamic therapy for the treatment of extramammary Paget's disease Br J Dermatol 2002; 1466:1000-1005.
6. Gold MH. A Single-Center, Open-Label Investigatory Study of Photodynamic Therapy in the Treatment of Moderate to Severe Acne Vulgaris with Aminolevulinic Acid Topical Solution 20% and Visible Blue Light. 2003. Poster presented at the 61st Annual Meeting of the American Academy of Dermatology, San Francisco, 2003.
7. Gold MH. A Single-Center, Open-Label Investigatory Study of Photodynamic Therapy in the Treatment of Photoaging with Aminolevulinic Acid Topical Solution 20% and Intense Pulsed Light. 2003. Poster presented at the 61st Annual Meeting of the American Academy of Dermatology, San Francisco, 2003.
8. Weinstein GD, Taylor JR, Glazer SD, et al. A Dose-Ranging Study of Photodynamic Therapy With Topical 5-Aminolevulinic Acid for Treatment of Actinic Keratoses. 2003. Poster presented at the 61st Annual Meeting of the American Academy of Dermatology, San Francisco, 2003.
9. Stender IM, Bech-Thomsen N, Poulsen T, et al. Photodynamic therapy with topical delta-aminolevulinic acid delays UV photo-carcinogenesis in hairless mice Photochem Photobiol 1997; 664:493-496.
10. Sharfaei S, Viau G, Lui H, et al. Systemic photodynamic therapy with aminolevulinic acid delays the appearance of ultraviolet-induced skin tumours in mice Br J Dermatol 2001; 1446:1207-1214.
11. Sharfaei S, Juzenas P, Moan J, et al. Weekly topical application of methyl aminolevulinate followed by light exposure delays the appearance of UV-induced skin tumours in mice Arch Dermatol Res 2002; 294:237-242.
12. Gruijl FR de, Leun JC van der. Development of skin tumours in hairless mice after discontinuation of ultraviolet irradiation Cancer Res 1991; 513:979-984.
13. Hurks HM, Out-Luiting C, Vermeer BJ, et al. In situ action spectra suggest that DNA damage is involved in ultraviolet radiation-induced immunosuppression in humans Photochem Photobiol 1997; 661:76-81.
14. Roberts LK, Beasley DG, Learn DB, et al. Ultraviolet spectral energy differences affect the ability of sunscreen lotions to prevent ultraviolet-radiation-induced immunosuppression Photochem Photobiol 1996; 636:874-884.
15. Learn DB, Beasley DG, Giddens LD, et al. Minimum doses of ultraviolet radiation required to induce murine skin edema and immunosuppression are different and depend on the ultraviolet emission spectrum of the source Photochem Photobiol 1995; 626: 1066-1075.